Why the study?
Does a dual chamber pacemaker with a rate drop response algorithm prevent syncope in a patient with malignant vasovagal syncope?
Does a dual chamber pacemaker with a rate drop response algorithm prevent syncope in a patient with malignant vasovagal syncope?
A dual chamber pacemaker with a rate drop response algorithm may be an effective therapy for preventing syncope in patients with malignant vasovagal syncope refractory to medical therapy.
Answers are grounded in this paper and cite their sources.
May support pacing in refractory malignant vasovagal syncope; leaves open confirmation in randomized trials.
A 29-year-old man with malignant vasovagal syncope presented with episodes of abrupt loss of consciousness associated with an aura, totaling more than 10 episodes over 3 months. Holter monitoring showed cardiac arrest with a duration of 15 seconds. Oral propranolol and disopyramide therapy failed to prevent the syncope. A dual chamber pacemaker with a rate drop response algorithm successfully prevented the syncope but not the aura. There may be multifactors involved in the mechanism of this syndrome. The patient has returned to a normal active life. This rate drop algorithm is an effective therapy for the prevention of syncope in malignant vasovagal syncope.
No takes yet. Share an insight, caveat, or question.
Abe et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: